Novel systemically active galanin receptor 2 ligands in depression-like behavior

Journal of Neurochemistry

Volumn 127, Issue 1, 2013, Pages 114-123

  Saar, Indrek ^a,b   Lahe, Jaanus ^a   Langel, Kent ^a   Runesson, Johan ^b   Webling, Kristin ^b   Järv, Jaak ^a   Rytkönen, Jussi ^c   Närvänen, Ale ^c   Bartfai, Tamas ^d   Kurrikoff, Kaido ^a   Langel, Ülo ^a,b  

^a UNIVERSITY OF TARTU   (Estonia)

^b STOCKHOLM UNIVERSITY   (Sweden)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

animal models of depression; depression; galanin; galanin receptor type 2; neuropeptide; tail suspension test

Indexed keywords

ANTIDEPRESSANT AGENT; GALANIN RECEPTOR 2; GALANIN RECEPTOR 3; IMIPRAMINE; J 17 PEPTIDE; J 18 PEPTIDE; J 19 PEPTIDE; J 20 PEPTIDE; J 21 PEPTIDE; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG MECHANISM; DRUG TISSUE LEVEL; EXPERIMENTAL TEST; FEMALE; FORCED SWIMMING TEST; HUMAN; HUMAN CELL; IN VIVO STUDY; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; TAIL SUSPENSION TEST; TOXICITY TESTING;

ANIMAL MODELS OF DEPRESSION; DEPRESSION; GALANIN; GALANIN RECEPTOR TYPE 2; NEUROPEPTIDE; TAIL SUSPENSION TEST;

AMINO ACID SEQUENCE; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BEHAVIOR, ANIMAL; BINDING, COMPETITIVE; CELL LINE, TUMOR; DEPRESSION; DRUG DESIGN; FEMALE; GALANIN; HINDLIMB SUSPENSION; HUMANS; IMIPRAMINE; LIGANDS; MALE; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PEPTIDES; RECEPTOR, GALANIN, TYPE 2; SWIMMING; TISSUE DISTRIBUTION;

ANIMALIA;

EID: 84884906508     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12274     Document Type: Article

References (34)

1. Barr A. M., Kinney J. W., Hill M. N., Lu X., Biros S., Rebek J. Jr, and, Bartfai T., (2006) A novel, systemically active, selective galanin receptor type-3 ligand exhibits antidepressant-like activity in preclinical tests. Neurosci. Lett. 405, 111-115.
2. Bulaj G., Green B. R., Lee H. K., et al,. (2008) Design, synthesis, and characterization of high-affinity, systemically-active galanin analogues with potent anticonvulsant activities. J. Med. Chem. 51, 8038-8047.
3. Cheng Y., and, Prusoff W. H., (1973) Relationship between inhibition constant (K1) and concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic-reaction. Biochem. Pharmacol. 22, 3099-3108.
4. Coppen A., (1967) The biochemistry of affective disorders. Br. J. Psychiatry 113, 1237-1264.
5. Duman R. S., Nakagawa S., and, Malberg J., (2001) Regulation of adult neurogenesis by antidepressant treatment. Neuropsychopharmacology 25, 836-844.
6. Fuxe K., Hedlund P., von Euler G., Lundgren K., Martire M., Ögren S. O., Eneroth P., and, Agnati L. F., (1991) Galanin/5-HT interactions in the rat central nervous system. Relevance for depression, in Galanin: A New Multifunctional Peptide in the Neuro-Endocrine System (, Hökfelt T., Bartfai T., Jacobowitz D., and, Ottoson D., eds), pp. 221-236. Macmillan Press Scientific & Medical, London, UK.
7. Grenhoff J., Nisell M., Ferré S., Aston-Jones G., and, Svensson T. H., (1993) Noradrenergic modulation of midbrain dopamine cell firing elicited by stimulation of the locus coeruleus in the rat. J. Neural Transm. Gen. Sect. 93, 11-25.
8. Habertortoli E., Amiranoff B., Loquet I., Laburthe M., and, Mayaux J. F., (1994) Molecular cloning of a functional human galanin receptor. Proc. Natl Acad. Sci. USA 91, 9780-9783.
9. Kehr J., Yoshitake T., Wang F. H., Razani H., Gimenez-Llort L., Jansson A., Yamaguchi M., and, Ogren S. O., (2002) Galanin is a potent in vivo modulator of mesencephalic serotonergic neurotransmission. Neuropsychopharmacology 27, 341-356.
10. Kokaia M., Holmberg K., Nanobashvili A., et al,. (2001) Suppressed kindling epileptogenesis in mice with ectopic overexpression of galanin. Proc. Natl Acad. Sci. USA 98, 14006-14011.
11. Kuteeva E., Wardi T., Hokfelt T., and, Ogren S. O., (2007) Galanin enhances and a galanin antagonist attenuates depression-like behaviour in the rat. Eur. Neuropsychopharmacol. 17, 64-69.
12. Kuteeva E., Hökfelt T., Wardi T., and, Ögren S. O., (2008a) Galanin, galanin receptor subtypes and depression-like behaviour. Cell. Mol. Life Sci. 65, 1854-1863.
13. Kuteeva E., Wardi T., Lundström L., Sollenberg U., Langel Ü., Hökfelt T., and, Ögren S. O., (2008b) Differential role of galanin receptors in the regulation of depression-like behavior and monoamine/stress- related genes at the cell body level. Neuropsychopharmacology 33, 2573-2585.
14. Larm J. A., Shen P. J., and, Gundlach A. L., (2003) Differential galanin receptor-1 and galanin expression by 5-HT neurons in dorsal raphe nucleus of rat and mouse: evidence for species-dependent modulation of serotonin transmission. Eur. J. Neurosci. 17, 481-493.
15. Lu X., Barr A. M., Kinney J. W., Sanna P., Conti B., Behrens M. M., and, Bartfai T., (2005) A role for galanin in antidepressant actions with a focus on the dorsal raphe nucleus. Proc. Natl Acad. Sci. USA 102, 874-879.
16. Lundberg J. M., and, Hokfelt T., (1986) Multiple coexistence of peptides and classical transmitters in peripheral autonomic and sensory neurons-functional and pharmacological implications. Prog. Brain Res. 68, 241-262.
17. Mazarati A. M., Baldwin R. A., Shinmei S., and, Sankar R., (2005) In vivo interaction between serotonin and galanin receptors types 1 and 2 in the dorsal raphe: implication for limbic seizures. J. Neurochem. 95, 1495-1503.
18. McEwen B. S., (2000) Effects of adverse experiences for brain structure and function. Biol. Psychiatry 48, 721-731.
19. Melander T., Hokfelt T., Rokaeus A., Cuello A. C., Oertel W. H., Verhofstad A., and, Goldstein M., (1986) Coexistence of galanin-like immunoreactivity with catecholamines, 5-hydroxytryptamine, GABA and neuropeptides in the rat CNS. J. Neurosci. 6, 3640-3654.
20. Morilak D. A., and, Frazer A., (2004) Antidepressants and brain monoaminergic systems: a dimensional approach to understanding their behavioural effects in depression and anxiety disorders. Int. J. Neuropsychopharmacol. 7, 193-218.
21. Ohtaki T., Kumano S., Ishibashi Y., et al,. (1999) Isolation and cDNA cloning of a novel galanin-like peptide (GALP) from porcine hypothalamus. J. Biol. Chem. 274, 37041-37045.
22. Prange A. J., (1964) The pharmacology and biochemistry of depression. Dis. Nerv. Syst. 25, 217-221.
23. Runesson J., Saar I., Lundström L., Järv J., and, Langel Ü., (2009) A novel GalR2-specific peptide agonist. Neuropeptides 43, 187-192.
24. Saar I., Runesson J., McNamara I., Järv J., Robinson J. K., and, Langel Ü., (2011) Novel galanin receptor subtype specific ligands in feeding regulation. Neurochem. Int. 58, 714-720.
25. Schildkraut J. J., (1965) The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am. J. Psychiatry 122, 509-522.
26. Shi T. J., Hua X. Y., Lu X., et al,. (2006) Sensory neuronal phenotype in galanin receptor 2 knockout mice: focus on dorsal root ganglion neurone development and pain behaviour. Eur. J. Neurosci. 23, 627-636.
27. Skofitsch G., and, Jacobowitz D. M., (1985) Immunohistochemical mapping of galanin-like neurons in the rat central nervous system. Peptides 6, 509-546.
28. Sollenberg U. E., Lundström L., Bartfai T., and, Langel Ü., (2006) M871-A novel peptide antagonist selectively recognizing the galanin receptor type 2. Int. J. Pept. Res. Ther. 12, 115-119.
29. Swanson C. J., Blackburn T. P., Zhang X. X., et al,. (2005) Anxiolytic- and antidepressant-like profiles of the galanin-3 receptor (Gal(3)) antagonists SNAP 37889 and SNAP 398299. Proc. Natl Acad. Sci. USA 102, 17489-17494.
30. Wang S., Hashemi T., Fried S., Clemmons A. L., and, Hawes B. E., (1998) Differential intracellular signaling of the GalR1 and GalR2 galanin receptor subtypes. Biochemistry 37, 6711-6717.
31. Weiss J. M., Bonsall R. W., Demetrikopoulos M. K., Emery M. S., and, West C. H., (1998) Galanin: a significant role in depression? Ann. N. Y. Acad. Sci. 863, 364-382.
32. WFMH. (2010) Mental Health and Chronic Physical Illnesses. The Need for Continued and Integrated Care. World Federation for Mental Health. http://www.wfmh.org/2010DOCS/WMHDAY2010.pdf.
33. Xu Z. Q. D., Shi T. J. S., and, Hokfelt T., (1998a) Galanin/GMAP- and NPY-like immunoreactivities in locus coeruleus and noradrenergic nerve terminals in the hippocampal formation and cortex with notes on the galanin-R1 and -R2 receptors. J. Comp. Neurol. 392, 227-251.
34. Xu Z. Q. D., Zhang X., Pieribone V. A., Grillner S., and, Hokfelt T., (1998b) Galanin-5-hydroxytryptamine interactions: electrophysiological, immunohistochemical and in situ hybridization studies on rat dorsal raphe neurons with a note on galanin R1 and R2 receptors. Neuroscience 87, 79-94.